PCRX.V · PharmaCorp Rx Inc.
Canada · RS rating 29 · As of 2026-10-14
| Price | 0.42 CAD |
|---|---|
| 1-day change | +5.0% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 48 / 19 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 19 / 19 |
| Industry group (rank) | Retail-Drug Stores (24) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.5% |
| Distance from 52-week high | +27.6% |
| Market cap (USD) | $56.8M |